APA (7th ed.) Citation

Potestio, L., Patruno, C., Ferrucci, S. M., Narcisi, A., Ortoncelli, M., Pezzolo, E., . . . Savoia, P. (2026). Longitudinal Response Trajectories with Dupilumab or Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Multicentre Real-World Study: IL-AD (Italian Landscape Atopic Dermatitis). Dermatology & Therapy, 16(7), 3493. https://doi.org/10.1007/s13555-026-01781-3

Chicago Style (17th ed.) Citation

Potestio, Luca, et al. "Longitudinal Response Trajectories with Dupilumab or Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Multicentre Real-World Study: IL-AD (Italian Landscape Atopic Dermatitis)." Dermatology & Therapy 16, no. 7 (2026): 3493. https://doi.org/10.1007/s13555-026-01781-3.

MLA (9th ed.) Citation

Potestio, Luca, et al. "Longitudinal Response Trajectories with Dupilumab or Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Multicentre Real-World Study: IL-AD (Italian Landscape Atopic Dermatitis)." Dermatology & Therapy, vol. 16, no. 7, 2026, p. 3493, https://doi.org/10.1007/s13555-026-01781-3.